Insider Transactions in Q4 2025 at Century Therapeutics, Inc. (IPSC)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2025
|
Chad Cowan Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
58,060
+5.26%
|
$0
$0.85 P/Share
|
|
Dec 12
2025
|
Brent Pfeiffenberger President and CEO |
BUY
Open market or private purchase
|
Direct |
52,000
+1.54%
|
$0
$0.58 P/Share
|
|
Dec 10
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-0.01%
|
$0
$0.53 P/Share
|
|
Dec 08
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
257
-0.06%
|
$0
$0.53 P/Share
|
|
Dec 08
2025
|
Gregory Russotti |
SELL
Open market or private sale
|
Direct |
526
-0.13%
|
$0
$0.53 P/Share
|
|
Nov 20
2025
|
Chad Cowan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,462
-0.55%
|
$0
$0.5 P/Share
|
|
Nov 19
2025
|
Brent Pfeiffenberger President and CEO |
BUY
Open market or private purchase
|
Direct |
35,000
+1.06%
|
$0
$0.5 P/Share
|
|
Nov 17
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
32,456
-0.99%
|
$0
$0.45 P/Share
|
|
Nov 03
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
292
-0.07%
|
$0
$0.59 P/Share
|